生物制剂可能对 COVID-19 哮喘患者有益。
Biologics may have a beneficial effect in asthma patients with COVID-19.
机构信息
Universidad de Alcalá, Madrid, Spain.
Hospital Universitario de Guadalajara, Guadalajara, Spain.
出版信息
Eur Respir J. 2021 Aug 26;58(2). doi: 10.1183/13993003.01076-2021. Print 2021 Aug.
Abstract
摘要
[网页链接]
相似文献
1
Biologics may have a beneficial effect in asthma patients with COVID-19.
Eur Respir J. 2021 Aug 26;58(2). doi: 10.1183/13993003.01076-2021. Print 2021 Aug.
2
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
J Allergy Clin Immunol. 2021 Aug;148(2):361-367.e13. doi: 10.1016/j.jaci.2021.06.006. Epub 2021 Jun 15.
3
High levels of anxiety during the COVID-19 pandemic as a risk factor of clinical worsening in patients with severe asthma.
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1381-1383. doi: 10.1016/j.jaip.2020.12.060. Epub 2021 Jan 10.
4
COVID-19 in a patient with severe asthma treated with Omalizumab.
Allergy. 2020 Oct;75(10):2705-2708. doi: 10.1111/all.14456. Epub 2020 Jun 27.
5
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.
Allergy. 2021 Mar;76(3):871-874. doi: 10.1111/all.14516. Epub 2020 Aug 11.
6
Asthma, biologics, corticosteroids, and coronavirus disease 2019.
Ann Allergy Asthma Immunol. 2020 Jul;125(1):12-13. doi: 10.1016/j.anai.2020.05.001. Epub 2020 May 6.
7
Asthma biologics: Underuse, overuse, and best use?
Ann Allergy Asthma Immunol. 2019 Apr;122(4):358-359. doi: 10.1016/j.anai.2018.12.016. Epub 2018 Dec 19.
8
Biologics, Clinical Context, and the Asthmas.
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1437-1439. doi: 10.1016/j.jaip.2019.03.012.
9
Severe asthma and biologics: Data are good, listening to patients is better.
Ann Allergy Asthma Immunol. 2021 Sep;127(3):285-286. doi: 10.1016/j.anai.2021.05.017.
10
Biologics for paediatric severe asthma: trick or TREAT?
Lancet Respir Med. 2019 Apr;7(4):294-296. doi: 10.1016/S2213-2600(19)30045-1. Epub 2019 Feb 26.
引用本文的文献
1
Antiviral roles of eosinophils in asthma and respiratory viral infection.
Front Allergy. 2025 Feb 28;6:1548338. doi: 10.3389/falgy.2025.1548338. eCollection 2025.
2
Treating asthma in the time of COVID.
J Allergy Clin Immunol. 2023 Apr;151(4):809-817. doi: 10.1016/j.jaci.2022.12.800. Epub 2022 Dec 14.
3
Recent developments in the immunopathology of COVID-19.
Allergy. 2023 Feb;78(2):369-388. doi: 10.1111/all.15593. Epub 2022 Dec 5.
4
Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients.
Allergy Asthma Clin Immunol. 2022 Aug 25;18(1):78. doi: 10.1186/s13223-022-00719-6.
5
Susceptibility of Patients with Airway Disease to SARS-CoV-2 Infection.
Am J Respir Crit Care Med. 2022 Sep 15;206(6):696-703. doi: 10.1164/rccm.202111-2547PP.
Zotero 插件